The Extraordinary General Meeting of Nobel Biocare approves all proposals of the Board of Directors

Following the settlement of the public tender offer of Danaher Corporation on December 11, 2014, Nobel Biocare Holding AG's Extraordinary General Meeting today endorsed all proposals put forward by the Board of Directors.

The new Board of Directors consists of Colin Davis, Jonathan P. Graham and Mischa Reis as Members and Philip Bernard Whitehead as Member and Chairman. All members have been elected for a term until the next Annual General Meeting.

The new Board of Directors resolved in his first meeting to move the date for the publication of the full year results to April 28, 2015 and the date of the next ordinary Annual General Meeting to June 29, 2015. Furthermore, Nobel Biocare Holding AG will no longer publish quarterly results.